ESLOY
Price
$165.88
Change
-$1.57 (-0.94%)
Updated
Dec 12 closing price
Capitalization
154.35B
83 days until earnings call
Intraday BUY SELL Signals
TRUMY
Price
$14.61
Change
-$0.17 (-1.15%)
Updated
Dec 12 closing price
Capitalization
21.89B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ESLOY vs TRUMY

Header iconESLOY vs TRUMY Comparison
Open Charts ESLOY vs TRUMYBanner chart's image
EssilorLuxottica
Price$165.88
Change-$1.57 (-0.94%)
Volume$41.62K
Capitalization154.35B
Terumo
Price$14.61
Change-$0.17 (-1.15%)
Volume$1.01M
Capitalization21.89B
ESLOY vs TRUMY Comparison Chart in %
ESLOY
Daily Signal:
Gain/Loss:
TRUMY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ESLOY vs. TRUMY commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOY is a StrongBuy and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ESLOY: $167.45 vs. TRUMY: $14.78)
Brand notoriety: ESLOY and TRUMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESLOY: 115% vs. TRUMY: 196%
Market capitalization -- ESLOY: $154.35B vs. TRUMY: $21.89B
ESLOY [@Pharmaceuticals: Other] is valued at $154.35B. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $21.89B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $192.25B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOY’s FA Score shows that 2 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • ESLOY’s FA Score: 2 green, 3 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, ESLOY is a better buy in the long-term than TRUMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOY’s TA Score shows that 5 TA indicator(s) are bullish while TRUMY’s TA Score has 3 bullish TA indicator(s).

  • ESLOY’s TA Score: 5 bullish, 4 bearish.
  • TRUMY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ESLOY is a better buy in the short-term than TRUMY.

Price Growth

ESLOY (@Pharmaceuticals: Other) experienced а -5.52% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was -4.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.04%. For the same industry, the average monthly price growth was -0.21%, and the average quarterly price growth was +2.71%.

Reported Earning Dates

ESLOY is expected to report earnings on Mar 06, 2026.

TRUMY is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($154B) has a higher market cap than TRUMY($21.9B). ESLOY has higher P/E ratio than TRUMY: ESLOY (55.06) vs TRUMY (25.71). ESLOY YTD gains are higher at: 43.401 vs. TRUMY (-24.205). TRUMY has higher annual earnings (EBITDA): 260B vs. ESLOY (6.71B). TRUMY has more cash in the bank: 217B vs. ESLOY (3.16B). ESLOY has less debt than TRUMY: ESLOY (14B) vs TRUMY (160B). TRUMY has higher revenues than ESLOY: TRUMY (1.06T) vs ESLOY (27.2B).
ESLOYTRUMYESLOY / TRUMY
Capitalization154B21.9B703%
EBITDA6.71B260B3%
Gain YTD43.401-24.205-179%
P/E Ratio55.0625.71214%
Revenue27.2B1.06T3%
Total Cash3.16B217B1%
Total Debt14B160B9%
FUNDAMENTALS RATINGS
ESLOY vs TRUMY: Fundamental Ratings
ESLOY
TRUMY
OUTLOOK RATING
1..100
5252
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
13100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
4781
P/E GROWTH RATING
1..100
2384
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (35) in the null industry is in the same range as TRUMY (65). This means that ESLOY’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOY's Profit vs Risk Rating (13) in the null industry is significantly better than the same rating for TRUMY (100). This means that ESLOY’s stock grew significantly faster than TRUMY’s over the last 12 months.

ESLOY's SMR Rating (94) in the null industry is in the same range as TRUMY (99). This means that ESLOY’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOY's Price Growth Rating (47) in the null industry is somewhat better than the same rating for TRUMY (81). This means that ESLOY’s stock grew somewhat faster than TRUMY’s over the last 12 months.

ESLOY's P/E Growth Rating (23) in the null industry is somewhat better than the same rating for TRUMY (84). This means that ESLOY’s stock grew somewhat faster than TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOYTRUMY
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 3 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
39%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 11 days ago
57%
Bullish Trend 20 days ago
68%
Declines
ODDS (%)
Bearish Trend 9 days ago
48%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
47%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOY
Daily Signal:
Gain/Loss:
TRUMY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OCIO37.940.27
+0.72%
ClearShares OCIO ETF
CARY20.920.01
+0.05%
Angel Oak Income ETF
PCEM10.97N/A
N/A
Polen Capital Em Mkts ex-China Gr ETF
SPEM47.26-0.05
-0.11%
SPDR® Portfolio Emerging Markets ETF
NBDS36.76-0.23
-0.62%
Neuberger Berman Disrupters ETF

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
-1.42%
ESLOF - ESLOY
58%
Loosely correlated
+0.05%
QGEN - ESLOY
43%
Loosely correlated
-0.48%
ALC - ESLOY
38%
Loosely correlated
-1.81%
SMMNY - ESLOY
38%
Loosely correlated
+1.27%
CRL - ESLOY
35%
Loosely correlated
-0.22%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.94%
HOCPY - TRUMY
51%
Loosely correlated
+0.37%
SSMXY - TRUMY
45%
Loosely correlated
+1.49%
SMTI - TRUMY
43%
Loosely correlated
-1.23%
OLYMY - TRUMY
40%
Loosely correlated
+0.23%
AZTA - TRUMY
39%
Loosely correlated
+2.74%
More